deltatrials
Recruiting OBSERVATIONAL NCT05231135

A Registry Study on HIV-related Lymphoma

Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group

Sponsor: Rotkreuzklinikum München gGmbH

Conditions AIDS Related Lymphoma HIV Related Lymphoma
Updated 4 times since 2022 Last updated: Apr 4, 2023 Started: Aug 25, 2021 Primary completion: Aug 31, 2024 Completion: Aug 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05231135, this observational or N/A phase trial focuses on AIDS Related Lymphoma and HIV Related Lymphoma and remains actively recruiting participants. Sponsored by Rotkreuzklinikum München gGmbH, it has been updated 4 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Mar 2022 – ~May 2023 · 14 months · monthly snapshotRecruiting~May 2023 – ~Jul 2024 · 14 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  3. May 2023 — Jul 2024 [monthly]

    Recruiting

  4. Mar 2022 — May 2023 [monthly]

    Recruiting

    First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rotkreuzklinikum München gGmbH
Data source: Rotkreuzklinikum München gGmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations